I’ve been writing about climate change and its risks for some time now, and I’ve been particularly interested in how…
Unlock the White House Watch newsletter for freeYour guide to what the 2024 US election means for Washington and the…
I recently profiled JPMorgan Chase & Co.'s (JPM) dividend increase and the underlying strength of…
Receive free Markets updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
With the S&P 500 hovering around 12-month highs despite macro jitters, a common question investors…
Receive free Deutsche Bank AG updatesWe’ll send you a myFT Daily Digest email rounding up…
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has…
Receive free Chinese economy updatesWe’ll send you a myFT Daily Digest email rounding up the…
These 3 are smaller than the competition, make no mistake they bring a lot to…
Insufficient access to renewable energy in their home markets has left Asia’s biggest chipmakers lagging…
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases.…
You can enable subtitles (captions) in the video player The story of Adani is the…
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB)…
Receive free SVB Financial Group updatesWe’ll send you a myFT Daily Digest email rounding up…
Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its…
© AP The US and Germany are under intense pressure from other allies to show…
Luxury fashion house Burberry (OTCPK:BURBY) (OTCPK:BBRYF) was facing some headwinds when I last covered it…
Sign in to your account